Brief: Epigenomics Resolves Capital Increase
08/10/2018 13:58
Oct 8 (Reuters) - Epigenomics AG ECXn.DE :
* DGAP-NEWS: EPIGENOMICS AG: CAPITAL INCREASE THROUGH RIGHTS
ISSUE
WITH SUBSCRIPTION RIGHTS OF EXISTING SHAREHOLDERS
* ISSUANCE OF UP TO 12,007,180 NEW SHARES
* SHAREHOLDERS GRANTED SUBSCRIPTION RIGHTS AT A RATIO OF 2:1
* SUBSCRIPTION PERIOD WILL LAST FROM OCTOBER 9 TO OCTOBER
22, 2018
* SUBSCRIPTION PRICE WILL BE ANNOUNCED DURING SUBSCRIPTION
PERIOD
* SHARE CAPITAL SHALL BE INCREASED FROM 24.0 MILLION EUR TO
UP TO
36.0 MILLION EUR BY ISSUING UP TO 12.0 NEW SHARES
Source text for Eikon: ID:nEQbzFrV1a
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns